StudyFinds on MSN
Study: Lack of Diversity in Drug Trials Can Harm Patients
Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback